Related Experiment Video
Updated: Apr 19, 2026

Methods to Evaluate Cytotoxicity and Immunosuppression of Combustible Tobacco Product Preparations
Published on: January 10, 2015
Evidence supporting product standards for carcinogens in smokeless tobacco products
Dorothy K Hatsukami1, Irina Stepanov2, Herb Severson3
1University of Minnesota, Masonic Cancer Center, Minneapolis, Minnesota. Department of Psychiatry, University of Minnesota, Minneapolis, Minnesota. hatsu001@umn.edu.
Abstract:
Smokeless tobacco products sold in the United States vary significantly in yields of nicotine and tobacco-specific nitrosamines (TSNA). With the passage of the Family Smoking Prevention and Tobacco Control Act, the Food and Drug Administration now has the authority to establish product standards. However, limited data exist determining the relative roles of pattern of smokeless tobacco use versus constituent levels in the smokeless tobacco product in exposure of users to carcinogens. In this study, smokeless tobacco users of brands varying in nicotine and TSNA content were recruited from three different regions in the U.S. Participants underwent two assessment sessions. During these sessions, demographic and smokeless tobacco use history information along with urine samples to assess biomarkers of exposure and effect were collected. During the time between data collection, smokeless tobacco users recorded the amount and duration of smokeless tobacco use on a daily basis using their diary cards. Results showed that independent of pattern of smokeless tobacco use and nicotine yields, levels of TSNA in smokeless tobacco products played a significant role in carcinogen exposure levels. Product standards for reducing levels of TSNA in smokeless tobacco products are necessary to decrease exposure to these toxicants and potentially to reduce risk for cancer.
Insights
Reducing tobacco-specific nitrosamines (TSNA) in smokeless tobacco is crucial for lowering carcinogen exposure. Product standards targeting TSNA levels are essential for public health, regardless of nicotine content or usage patterns.
Area of Science:
- Toxicology
- Public Health
- Tobacco Control
Background:
- Smokeless tobacco products in the U.S. exhibit wide variations in nicotine and tobacco-specific nitrosamine (TSNA) yields.
- The Food and Drug Administration has regulatory authority to set product standards for tobacco products.
- Limited data exist on the comparative impact of smokeless tobacco use patterns versus constituent levels on user carcinogen exposure.
Purpose of the Study:
- To investigate the role of smokeless tobacco constituent levels, specifically TSNA, in carcinogen exposure.
- To differentiate the impact of TSNA levels from usage patterns on user exposure to carcinogens.
- To inform potential product standards for smokeless tobacco.
Main Methods:
- Recruited smokeless tobacco users from three U.S. regions, representing brands with varying nicotine and TSNA content.
- Collected demographic and detailed smokeless tobacco use history.
- Analyzed urine samples for biomarkers of exposure and effect.
- Utilized daily diary cards to record amount and duration of smokeless tobacco use.
Main Results:
- Levels of TSNA in smokeless tobacco products significantly influenced carcinogen exposure levels.
- This effect was independent of the pattern of smokeless tobacco use and nicotine yields.
- Higher TSNA content correlated with increased exposure biomarkers.
Conclusions:
- Reducing TSNA levels in smokeless tobacco products is a necessary strategy to decrease user exposure to carcinogens.
- Implementing product standards for TSNA reduction can potentially lower cancer risk associated with smokeless tobacco use.
- Regulatory action on TSNA content is a vital public health intervention.
More Related Videos
09:30A Microcontroller Operated Device for the Generation of Liquid Extracts from Conventional Cigarette Smoke and Electronic Cigarette Aerosol
Published on: January 18, 2018
11:38High Content Screening Analysis to Evaluate the Toxicological Effects of Harmful and Potentially Harmful Constituents HPHC
Published on: May 10, 2016
Related Concept Videos
Mutagenicity and Carcinogenicity
Criteria for Causality: Bradford Hill Criteria - II
Stimulants
Cocaine can be administered via snorting, injection, or smoking. It primarily functions by blocking the reuptake of dopamine, resulting in a euphoric high characterized by an intense sensation of happiness and...
Cancer Prevention
Some...
Statistical Methods for Analyzing Epidemiological Data
Criteria for Causality: Bradford Hill Criteria - I